Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

FDA Approves Telotristat Ethyl for Carcinoid Syndrome Diarrhea

March 1st 2017

The FDA has approved telotristat ethyl (Xermelo) for use in combination with somatostatin analog (SSA) as a treatment for carcinoid syndrome diarrhea in patients with metastatic neuroendocrine tumors that cannot be adequately controlled by SSA therapy alone.

Rolapitant Recommended for EU Approval for CINV

February 27th 2017

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of oral rolapitant (Varuby; Varubi in US) for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy.

Prophylactic Letermovir Limits CMV Infections Post-Transplantation

February 27th 2017

Prophylactic treatment with letermovir lowered the rates of cytomegalovirus infection and all-cause mortality compared with placebo for CMV-seropositive patients following an allogeneic hematopoietic stem cell transplant.

Dr. Marty on Letermovir for CMV Prevention After Stem Cell Transplant

February 26th 2017

Francisco Marty, MD, Dana-Farber Cancer Institute, discusses the initial results of the Phase III trial evaluating letermovir for CMV after bone marrow transplant.

Precision Medicine and the Future of Pancreatic Cancer

February 16th 2017

PEGPH20 in Advanced Pancreatic Cancer

February 16th 2017

The Potential for Immunotherapy in Pancreatic Cancer

February 16th 2017

Adjuvant Therapy in Pancreatic Cancer

February 16th 2017

Considerations in Locally Advanced Pancreatic Cancer

February 16th 2017

Ongoing Neoadjuvant Clinical Trials in Pancreatic Cancer

February 16th 2017

Neoadjuvant Therapy in Locally Advanced Pancreatic Cancer

February 16th 2017

Advanced Pancreatic Cancer: Quality of Life Considerations

February 16th 2017

Sequencing Decisions in Advanced Pancreatic Cancer

February 16th 2017

Liposomal Irinotecan in Advanced Pancreatic Cancer

February 16th 2017

Frontline Decisions in Metastatic Pancreatic Cancer

February 16th 2017

Metastatic Pancreatic Cancer: Dosing Strategies in the Frontline Setting

February 16th 2017

Current Practice With Molecular Testing in Pancreatic Cancer

February 16th 2017

Multidisciplinary Care in Advanced Pancreatic Cancer

February 16th 2017

APL Treatment Moving Forward

January 17th 2017

Maintenance Therapy and Treating Relapse in APL

January 17th 2017